- Home
- RPRX vs ENPH Comparison
RPRX vs ENPH Comparison
Compare RPRX & ENPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- ENPH
- Stock Information
- Founded
- RPRX 1996
- ENPH 2006
- Country
- RPRX United States
- ENPH United States
- Employees
- RPRX N/A
- ENPH N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- ENPH Semiconductors
- Sector
- RPRX Health Care
- ENPH Technology
- Exchange
- RPRX Nasdaq
- ENPH Nasdaq
- Market Cap
- RPRX 11.7B
- ENPH 9.6B
- IPO Year
- RPRX 2020
- ENPH 2012
- Fundamental
- Price
- RPRX $25.23
- ENPH $73.28
- Analyst Decision
- RPRX Strong Buy
- ENPH Buy
- Analyst Count
- RPRX 6
- ENPH 31
- Target Price
- RPRX $41.67
- ENPH $100.34
- AVG Volume (30 Days)
- RPRX 3.2M
- ENPH 3.2M
- Earning Date
- RPRX 02-13-2025
- ENPH 02-04-2025
- Dividend Yield
- RPRX 3.33%
- ENPH N/A
- EPS Growth
- RPRX 518.56
- ENPH N/A
- EPS
- RPRX 2.55
- ENPH 0.44
- Revenue
- RPRX $2,266,003,000.00
- ENPH $1,250,240,000.00
- Revenue This Year
- RPRX $12.21
- ENPH N/A
- Revenue Next Year
- RPRX $11.13
- ENPH $30.91
- P/E Ratio
- RPRX $9.88
- ENPH $168.44
- Revenue Growth
- RPRX N/A
- ENPH N/A
- 52 Week Low
- RPRX $24.05
- ENPH $58.33
- 52 Week High
- RPRX $31.66
- ENPH $141.63
- Technical
- Relative Strength Index (RSI)
- RPRX 43.88
- ENPH 50.85
- Support Level
- RPRX $24.05
- ENPH $65.10
- Resistance Level
- RPRX $25.28
- ENPH $76.01
- Average True Range (ATR)
- RPRX 0.55
- ENPH 3.65
- MACD
- RPRX 0.00
- ENPH 0.46
- Stochastic Oscillator
- RPRX 46.46
- ENPH 62.16
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About ENPH Enphase Energy Inc.
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.